Qualitative research in pharmaceuticals often involves participants like healthcare professionals, patients, service providers or care-givers. Sessions cover sensitive topics. Data security is often a procurement non-negotiable (not just a tickmark). Stakeholders watching from the backroom include medical affairs, regulatory, and commercial teams; all of who could have a variety of questions.
This guide covers the tools that qualitative research teams in pharma actually need, what to look for in each category, and where most platforms fall short for Pharma sector.
TL;DR
- Pharma qual research is more complex than standard B2B research: participants are HCPs or patients, topics are sensitive, and compliance requirements are strict
- Most general research platforms fail pharma procurement because they lack security certifications, use customer data for AI training or have inadequate backroom controls
- Pharma teams need six specific tool capabilities: a certified session conductor, verified panels of HCP or patients, clinical-grade transcription, compliant backroom access, auditable AI analysis, and reporting
- flowres.io covers pharma-specific platform requirements: ISO 27001 certified, closed AI environment, client backroom with role-based access, and custom vocabulary for clinical transcription
What makes pharma qual research different from mainstream research
Before listing tools, it is worth understanding what distinguishes pharmaceutical market research from standard B2B or consumer research.
Participant types are niche, often specialised.
Pharma qual research typically involves key opinion leaders (KOLs), general practitioners, specialists, nurses, payers, or patients. Recruiting them requires panels with verified professional credentials.
Topics are sensitive.
Sessions may cover patient outcomes, prescribing behaviour, competitive brand perceptions, or unpublished clinical data. Confidentiality and data handling need to be airtight.
Compliance requirements are strict.
Depending on the region and the research type, teams may need to comply with HIPAA (US), GDPR (EU), ICH E6 Good Clinical Practice guidelines, and local pharmaceutical marketing codes. Some research types also require ethics committee approval.
Backroom management is complex.
A KOL advisory board session might have a moderator, a co-moderator, a medical affairs lead, a brand manager, a regulatory reviewer, and an agency team; all needing different levels of access to what participants say during sessions.
The six tools pharma qual teams consider
| Tool category | What pharma needs | Why generic tools fall short |
|---|---|---|
| Qualitative research platform | ISO 27001, SOC 2, GDPR, closed AI environment | Lack certification or use data for AI training |
| HCP or patient panel | Audience-appropriate sourcing, credential checks where relevant, incentive controls | May not extensively verify specialists’ credentials |
| Transcription | Custom vocabulary addition leads to accurate terminology coverage | Unreviewed transcripts can misstate specialist terms |
| Backroom access | Availability of role-based permissions, private moderator channel | Basic Zoom observer links have no access controls |
| AI analysis | Fully cited findings, closed environment | AI generates findings from outside the dataset |
| Reporting | Audience-specific output (medical affairs, commercial, regulatory) | Single-format reports do not serve multiple stakeholders |
A secure qualitative research platform
For pharma, the tool that runs your IDIs and advisory boards needs to meet a specific set of requirements; that go well beyond a standard qualitative platform.
Security certifications
ISO 27001 and SOC 2 Type II are the baseline. For research involving patient data in the US, confirm whether a Business Associate Agreement (BAA) is available for HIPAA compliance.
Data residency
This matters for cross-border research involving EU participants under GDPR. Users evaluating tools must check where session recordings and transcripts are stored, under which legal jurisdiction, and for how long.
AI data handling
Patient and HCP data cannot be used as AI training input without explicit consent and contractual protection. If the platform uses AI for transcription or analysis, confirm that data is not used to train models and is processed in a closed environment.
No external accounts needed for observers
Observers should be able to join without creating platform accounts that leave data traces. Invite links with controlled access are the appropriate mechanism.
flowres.io is built to meet these requirements. Additionally, it integrates with Respondent.io for HCP and professional audience recruitment. This way, participant sourcing, scheduling, sessions, transcription, and analysis all run inside one platform. The platform holds an ISO 27001 certification, operates a fully closed AI environment that doesn't use customer data for model training. It lets medical affairs, regulatory, and commercial observers join sessions via an invite link without them having to create separate accounts or leave data traces on the platform.
For pharma teams navigating security reviews, flowres.io's trust documentation is available at flowres.io/trust-center.
A verified HCP and patient panel
Mainstream consumer research panels are not suitable for KOL or HCP recruitment. You need a panel provider that verifies professional credentials, understands pharma research ethics, and has experience managing incentive payments to healthcare professionals in compliance with local transfer-of-value regulations.
Specialist pharma research panel providers include M3 (strong for physician panels in Europe and Asia), Sermo (US and international physicians), and Rare Patient Voice (for rare disease patient communities). These are not general-purpose tools - they exist specifically for healthcare and life sciences audiences. Such tools are not built to support additional screening for health literacy, disease experience, and willingness to discuss sensitive topics.
Compliant transcription and translation
Verbatim transcripts of HCP or patient sessions contain clinical terminology, brand names, compound names, and dosing discussions. Generic transcription tools trained on consumer audio tend to perform poorly on such vocabulary.
Look for a transcription tool that allows input of custom vocabulary i.e. allows users to add drug names, INN terms, indication-specific language, and competitor product names, so they appear correctly in the transcript.
For multi-market studies, translation needs to handle both, clinical accuracy and conversational fluency. A general-purpose translation layer is considered inadequate for research where regulatory teams are users of the research output.
flowres.io supports custom vocabulary in transcription - before fieldwork begins, you can add drug names, compound names and clinical terms specific to your therapeutic area. Thus, it generates accurate transcripts across 19 languages, which covers most major pharmaceutical markets.
Backroom access management
A KOL advisory board in pharma often has ten to fifteen observers from different functions, each with different information needs. Regulatory reviewers may need to see everything, whereas Commercial observers might have restrictions on what they can hear during competitive discussions. Agency teams may need view-only access, without the ability to download recordings.
The backroom needs role-based access, a private channel for observers to send questions to the moderator, and the ability to restrict downloads at the session level.
flowres.io's client backroom is purpose-built for exactly this. Observers join via invite link with no platform account required. The backroom chat is separate from the session - observers can @mention the moderator to pass a question through, without the participant or other observers seeing it. Session recordings and transcripts are accessible to permissioned observers after the session, with download controls set per session. Standard video conferencing tools do not offer this level of access management to KOL advisory boards and large, mixed observer groups).
AI-assisted analysis with auditability
Pharma market research findings feed into brand strategy, medical education content, and sometimes regulatory submissions. Any AI-assisted analysis tool used in this context needs to show the source of every finding - the speaker, the timestamp, and the verbatim quote.
Analysis that produces themes without citations is not usable in a regulated environment. For any finding, users need to be able to show, exactly where it came from and verify that it accurately reflects what was said.
flowres.io's AI analysis is designed for this standard. Every finding is cited back to the speaker, the verbatim quote, and the timestamp in the recording. Nothing is inferred or generated outside what was actually said. If a medical affairs lead or regulatory reviewer challenges a particular finding, users can pull up the exact moment in the video in seconds. AI runs across all sessions in a study simultaneously, so cross-session patterns surface faster than manual thematic coding - without compromising auditability for speed.
A reporting layer that works for medical affairs and commercial teams
Pharma research output goes to multiple audiences with different information needs. Medical affairs wants verbatim quotes and clinical accuracy. Commercial wants strategic implications and competitive positioning. Regulatory wants evidence that the research was conducted properly.
A reporting tool that forces everyone into the same format wastes time and often means the document ends up being too clinical for commercial and too light on detail for medical affairs.
flowres.io lets you select specific findings, clips, and quotes to build audience-specific outputs from the same study data. SlideBuilder connects those findings directly to PowerPoint, so medical affairs, commercial, and agency teams each can get a deck addressing issues relevant to each team.
What most platforms get wrong for pharma
Lack of certification.
Most general-purpose research platforms do not hold ISO 27001 or SOC 2. This alone disqualifies them from most pharma procurement processes.
Using participant data for AI training.
General AI tools use input data to improve their models. In pharma research, this is not acceptable for HCP or patient data. The AI environment must be closed.
Inadequate Backroom-related features.
A Zoom link with observer access is not a backroom. It does not separate observer chat from the session, does not allow role-based access controls, and does not give the moderator a private channel for live guidance.
Transcription struggles with clinical vocabulary.
Drug names, dosing schedules, and clinical terms come through incorrectly in generic transcription tools, which requires extensive manual correction before analysis can begin.
Key takeaways
| Requirement | What to look for | Red flag |
|---|---|---|
| Security | ISO 27001, SOC 2 Type II, BAA available | No certifications listed or certifications not made available (even on request) |
| AI data use | Closed environment, no training on customer data | Vague or no answer to "Do you train on our data?" |
| Transcription | Custom vocabulary support, major languages | Generic model with no training in clinical terminologies |
| Backroom | Role-based access, private moderator chat | Standard Zoom link with no access controls |
| Analysis | Source citations to speaker and timestamp | Themes with no traceable quotes |
| Panel | Verified credentials, transfer of value compliance | General consumer panel offered for HCP research |
See how flowres.io supports secure, auditable qualitative research for pharma teams.
FAQs
What qualitative research methods are used in pharma?
The most common are KOL advisory boards (groups of physicians or specialists advising on clinical or commercial topics), HCP IDIs (in-depth interviews with individual prescribers or payers), patient IDIs and dyads, and concept testing for marketing materials or patient support programmes.
Does pharma market research need ethics approval?
It depends on the research type and region. Promotional market research that does not involve patients generally does not require ethics approval. Research involving patients, clinical data, or any research that could influence a prescribing decision may require review. Confirm with your compliance team before fieldwork begins.
What is a KOL in pharma market research?
A key opinion leader is a physician, specialist, or researcher whose views are considered influential in a therapeutic area. KOL advisory boards gather groups of these experts to advise on clinical, scientific, or commercial topics. Managing their scheduling, incentive payments, and session access requires specialist infrastructure compared to general consumer research.
How do you handle HIPAA compliance in qualitative research?
For research involving identifiable patient health information in the US, you need a Business Associate Agreement with any platform that stores or processes that data. You also need to ensure data is encrypted in transit and at rest, that access is role-controlled, and that data is retained only for as long as required by your research protocol.
What is transfer-of-value in HCP research?
Transfer of value refers to any payment, gift, or benefit given to a healthcare professional, including research incentives. Most countries have disclosure requirements for these payments. Pharma teams running HCP research need to track and report incentive payments to healthcare professionals in line with local codes (EFPIA in Europe, Sunshine Act in the US).
Enjoy reading flowres.io?
Ayushi Jain
(Content Writer)
She is a content writer specializing in the intersection of human inquiry and modern efficiency. Through her work at flowres.io, she explores how qualitative research is evolving and highlights the tools that help researchers maintain their creative flow.
Posted on: Nov 09, 2026
